Inappropriate Antidiuretic Hormone Secretion and Cerebral Salt-Wasting Syndromes in Neurological Patients

Haiying Cui, Guangyu He, Shuo Yang, You Lv, Zongmiao Jiang, Xiaokun Gang, Guixia Wang, Haiying Cui, Guangyu He, Shuo Yang, You Lv, Zongmiao Jiang, Xiaokun Gang, Guixia Wang

Abstract

The differential diagnosis of syndrome of inappropriate antidiuretic hormone secretion (SIADH) and cerebral salt-wasting syndrome (CSWS) in patients with neurological disorders has been a perplexing clinical controversy. The purpose of this review is to summarize the characteristics and risk factors of patients with different types of neurological disorders complicated by hyponatremia (HN) and review various methods to distinguish SIADH from CSWS. Common neurological disorders with high rates of HN include subarachnoid hemorrhage (SAH), traumatic brain injuries, stroke, cerebral tumors, central nervous system (CNS) infections, and Guillain-Barré syndrome (GBS), which have their own characteristics. Extracellular volume (ECV) status of patients is a key point to differentiate SIADH and CSWS, and a comprehensive assessment of relevant ECV indicators may be useful in differentiating these two syndromes. Besides, instead of monitoring the urinary sodium excretion, more attention should be paid to the total mass balance, including Na+, K+, Cl-, and extracellular fluid. Furthermore, the dynamic detection of fractional excretions (FE) of urate before and after correction of HN and a short-term infusion of isotonic saline solution may be useful in identifying the etiology of HN. As for brain natriuretic peptide (BNP) or N-terminal prohormone of BNP (NT-proBNP), more prospective studies and strong evidence are needed to determine whether there is a pertinent and clear difference between SIADH and CSWS.

Keywords: central nervous system; cerebral salt-wasting syndrome; differential diagnosis; hyponatremia; syndrome of inappropriate antidiuretic hormone secretion.

Copyright © 2019 Cui, He, Yang, Lv, Jiang, Gang and Wang.

Figures

Figure 1
Figure 1
The process to differentiate cerebral salt-wasting syndrome (CSWS) from syndrome of inappropriate antidiuretic hormone secretion (SIADH).

References

    1. Agha A., Sherlock M., Phillips J., Tormey W., Thompson C. J. (2005). The natural history of post-traumatic neurohypophysial dysfunction. Eur. J. Endocrinol. 152, 371–377. 10.1530/eje.1.01861
    1. Althaus A. E., Krapf R. (2018). Quality and cost considerations in hyponatraemic patients needing hospitalisation. Swiss Med. Wkly. 148:w14662. 10.4414/smw.2018.14662
    1. Arieff A. I., Gabbai R., Goldfine I. D. (2017). Cerebral salt-wasting syndrome: diagnosis by urine sodium excretion. Am. J. Med. Sci. 354, 350–354. 10.1016/j.amjms.2017.05.007
    1. Bartoli W. P., Davis J. M., Pate R. R., Ward D. S., Watson P. D. (1993). Weekly variability in total body water using 2H2O dilution in college-age males. Med. Sci. Sports Exerc. 25, 1422–1428. 10.1249/00005768-199312000-00017
    1. Berendes E., Scherer R., Schuricht G., Rol R., Hengst K. (1992). Massive natriuresis and polyuria after triple craniocervical subarachnoid hemorrhage: cerebral salt wasting syndrome? Anasthesiol. Intensivmed. Notfallmed. Schmerzther. 27, 445–448. 10.1055/s-2007-1000333
    1. Berendes E., Walter M., Cullen P., Prien T., Van Aken H., Horsthemke J., et al. . (1997). Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet. 349, 245–249. 10.1016/S0140-6736(96)08093-2
    1. Berkenbosch J. W., Lentz C. W., Jimenez D. F., Tobias J. D. (2002). Cerebral salt wasting syndrome following brain injury in three pediatric patients: suggestions for rapid diagnosis and therapy. Pediatr. Neurosurg. 36, 75–79. 10.1159/000048356
    1. Betjes M. G. (2002). Hyponatremia in acute brain disease: the cerebral salt wasting syndrome. Eur. J. Intern. Med. 13, 9–14. 10.1016/S0953-6205(01)00192-3
    1. Bitew S., Imbriano L., Miyawaki N., Fishbane S., Maesaka J. K. (2009). More on renal salt wasting without cerebral disease: response to saline infusion. Clin. J. Am. Soc. Nephrol. 4, 309–315. 10.2215/CJN.02740608
    1. Black N., Hamada H. (2018). Possible anti-VGKC autoimmune limbic encephalitis associated with SIADH. BMJ Case Rep. 2018:bcr-2017-223484. 10.1136/bcr-2017-223484
    1. Bunnag S., Pattanasombatsakul K. (2012). N-terminal-pro-brain natriuretic peptide for the differential diagnosis of hypovolemia vs. euvolemia in hyponatremic patients. J. Med. Assoc. Thai. 95 (Suppl. 3), S69–74.
    1. Cakirgoz M. Y., Duran E., Topuz C., Kara D., Turgut N., Turkmen U. A., et al. . (2014). Syndrome of inappropriate antidiuretic hormone secretion related to Guillain-Barre syndrome after laparoscopic cholecystectomy. Braz. J. Anesthesiol. 64, 195–198. 10.1016/j.bjane.2013.03.009
    1. Carlotti A. P., Bohn D., Mallie J. P., Halperin M. L. (2001). Tonicity balance, and not electrolyte-free water calculations, more accurately guides therapy for acute changes in natremia. Intensive Care Med. 27, 921–924. 10.1007/s001340100911
    1. Colls B. M. (2003). Guillain-Barre syndrome and hyponatraemia. Intern. Med. J. 33, 5–9. 10.1046/j.1445-5994.2002.00322.x
    1. Cooper W. C., Green I. J., Wang S. P. (1965). Cerebral Salt-Wasting associated with the Guillain-Barre syndrome. Arch. Intern. Med. 116, 113–119. 10.1001/archinte.1965.03870010115014
    1. Cote D. J., Alzarea A., Acosta M. A., Hulou M. M., Huang K. T., Almutairi H., et al. . (2016). Predictors and rates of delayed symptomatic hyponatremia after transsphenoidal surgery: a systematic review. World Neurosurg. 88, 1–6. 10.1016/j.wneu.2016.01.022
    1. Cotton M. F., Donald P. R., Schoeman J. F., Aalbers C., Van Zyl L. E., Lombard C. (1991). Plasma arginine vasopressin and the syndrome of inappropriate antidiuretic hormone secretion in tuberculous meningitis. Pediatr. Infect. Dis. J. 10, 837–842. 10.1097/00006454-199111000-00009
    1. Cotton M. F., Donald P. R., Schoeman J. F., Van Zyl L. E., Aalbers C., Lombard C. J. (1993). Raised intracranial pressure, the syndrome of inappropriate antidiuretic hormone secretion, and arginine vasopressin in tuberculous meningitis. Childs Nerv. Syst. 9, 10–15; discussion 15–16. 10.1007/BF00301927
    1. Cuesta M., Hannon M. J., Thompson C. J. (2016). Diagnosis and treatment of hyponatraemia in neurosurgical patients. Endocrinol. Nutr. 63, 230–238. 10.1016/j.endonu.2015.12.007
    1. Cuesta M., Thompson C. J. (2016). The syndrome of inappropriate antidiuresis (SIAD). Best Pract. Res. Clin. Endocrinol. Metab. 30, 175–187. 10.1016/j.beem.2016.02.009
    1. Czupryna P., Moniuszko A., Garkowski A., Pancewicz S., Guziejko K., Zajkowska J. (2014). Evaluation of hyponatraemia in patients with tick-borne encephalitis–a preliminary study. Ticks Tick Borne Dis. 5, 284–286. 10.1016/j.ttbdis.2013.11.005
    1. Czupryna P., Moniuszko A., Garkowski A., Pancewicz S., Zajkowska J. (2016). Comparison of hyponatremia and SIADH frequency in patients with tick borne encephalitis and meningitis of other origin. Scand. J. Clin. Lab. Invest. 76, 159–164. 10.3109/00365513.2015.1129669
    1. Czupryna P., Moniuszko-Malinowska A., Garkowski A., Dunaj J., Swierzbinska R., Pancewicz S., et al. . (2017). Usefulness of copeptin as a potential biomarker in TBE. Biomarkers 22, 321–325. 10.1080/1354750X.2016.1264999
    1. Das S. R., Drazner M. H., Dries D. L., Vega G. L., Stanek H. G., Abdullah S. M., et al. . (2005). Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 112, 2163–2168. 10.1161/CIRCULATIONAHA.105.555573
    1. Deitelzweig S., Amin A., Christian R., Friend K., Lin J., Lowe T. J. (2013). Health care utilization, costs, and readmission rates associated with hyponatremia. Hosp. Pract. 41, 89–95. 10.3810/hp.2013.02.1014
    1. Gang X., Zhang Y., Pan X., Guo W., Li Z., Wang Y., et al. . (2018). Hyponatremia: prevalence and characteristics in internal medicine patients in southeast of China. Medicine 97:e13389. 10.1097/MD.0000000000013389
    1. Giuliani C., Cangioli M., Beck-Peccoz P., Faustini-Fustini M., Fiaccadori E., Peri A. (2013). Awareness and management of hyponatraemia: the Italian Hyponatraemia survey. J. Endocrinol. Invest. 36, 693–698. 10.3275/8925
    1. Gray J. R., Morbitzer K. A., Liu-DeRyke X., Parker D., Zimmerman L. H., Rhoney D. H. (2014). Hyponatremia in patients with spontaneous intracerebral hemorrhage. J. Clin. Med. 3, 1322–1332. 10.3390/jcm3041322
    1. Greenberg A., Verbalis J. G., Amin A. N., Burst V. R., Chiodo J. A., III., Chiong J. R., et al. . (2015). Current treatment practice and outcomes. Report of the hyponatremia registry. Kidney Int. 88, 167–177. 10.1038/ki.2015.4
    1. Greenleaf J. E., Bernauer E. M., Young H. L., Morse J. T., Staley R. W., Juhos L. T., et al. . (1977). Fluid and electrolyte shifts during bed rest with isometric and isotonic exercise. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 42, 59–66. 10.1152/jappl.1977.42.1.59
    1. Gurnurkar S., Villacres S., Warner L., Chegondi M. (2018). Successful use of fludrocortisone in a child with refractory cerebral salt wasting syndrome: a case report and review of literature. Cureus 10:e3505. 10.7759/cureus.3505
    1. Hankey G. J. (2017). Stroke. Lancet. 389, 641–654. 10.1016/S0140-6736(16)30962-X
    1. Hannon M. J., Behan L. A., O'Brien M. M., Tormey W., Ball S. G., Javadpour M., et al. (2014). Hyponatremia following mild/moderate subarachnoid hemorrhage is due to SIAD and glucocorticoid deficiency and not cerebral salt wasting. J. Clin. Endocrinol. Metab. 99, 291–298. 10.1210/jc.2013-3032
    1. Hannon M. J., Finucane F. M., Sherlock M., Agha A., Thompson C. J. (2012). Clinical review: disorders of water homeostasis in neurosurgical patients. J. Clin. Endocrinol. Metab. 97, 1423–1433. 10.1210/jc.2011-3201
    1. Hannon M. J., Thompson C. J. (2014). Neurosurgical hyponatremia. J. Clin. Med. 3, 1084–1104. 10.3390/jcm3041084
    1. Hao J., Li Y., Zhang X., Pang C., Wang Y., Nigwekar S. U., et al. . (2017). The prevalence and mortality of hyponatremia is seriously underestimated in Chinese general medical patients: an observational retrospective study. BMC Nephrol. 18:328. 10.1186/s12882-017-0744-x
    1. Harrigan M. R. (2001). Cerebral salt wasting syndrome. Crit. Care Clin. 17, 125–138. 10.1016/S0749-0704(05)70155-X
    1. Hart D., Metz J. (1962). The estimation of red cell volume with 51Cr-labelled erythrocytes and plasma volume with radioiodinated human serum albumin. J. Clin. Pathol. 15, 459–461. 10.1136/jcp.15.5.459
    1. Hasan D., Lindsay K. W., Wijdicks E. F., Murray G. D., Brouwers P. J., Bakker W. H., et al. . (1989). Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. Stroke. 20, 1156–1161. 10.1161/01.STR.20.9.1156
    1. Hiew F. L., Winer J. B., Rajabally Y. A. (2016). Hyponatraemia in Guillain-Barre syndrome revisited. Acta Neurol. Scand. 133, 295–301. 10.1111/ane.12459
    1. Hoffman H., Ziechmann R., Gould G., Chin L. S. (2018). The impact of aneurysm location on incidence and etiology of hyponatremia following subarachnoid hemorrhage. World Neurosurg. 110, e621–e626. 10.1016/j.wneu.2017.11.058
    1. Holland-Bill L., Christiansen C. F., Heide-Jorgensen U., Ulrichsen S. P., Ring T., Jorgensen J. O., et al. . (2015). Hyponatremia and mortality risk: a Danish cohort study of 279 508 acutely hospitalized patients. Eur. J. Endocrinol. 173, 71–81. 10.1530/EJE-15-0111
    1. Hoyle G. E., Chua M., Soiza R. L. (2006). Prevalence of hyponatremia in elderly patients. J. Am. Geriatr. Soc. 54, 1473; author reply 1473–1474. 10.1111/j.1532-5415.2006.00872.x
    1. Hussain N. S., Piper M., Ludlam W. G., Ludlam W. H., Fuller C. J., Mayberg M. R. (2013). Delayed postoperative hyponatremia after transsphenoidal surgery: prevalence and associated factors. J. Neurosurg. 119, 1453–1460. 10.3171/2013.8.JNS13411
    1. Inamdar P., Masavkar S., Shanbag P. (2016). Hyponatremia in children with tuberculous meningitis: a hospital-based cohort study. J. Pediatr. Neurosci. 11, 182–187. 10.4103/1817-1745.193376
    1. Inoue M., Kojima Y., Shirakashi Y., Kanda M., Shibasaki H. (2010). A case of Guillain-Barre syndrome accompanied by syndrome of inappropriate secretion of antidiuretic hormone. Rinsho. Shinkeigaku. 50, 710–713. 10.5692/clinicalneurol.50.710
    1. Irani S. R., Alexander S., Waters P., Kleopa K. A., Pettingill P., Zuliani L., et al. . (2010). Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 133, 2734–2748. 10.1093/brain/awq213
    1. Ishikawa S. E., Saito T., Kaneko K., Okada K., Kuzuya T. (1987). Hyponatremia responsive to fludrocortisone acetate in elderly patients after head injury. Ann. Intern. Med. 106, 187–191. 10.7326/0003-4819-106-2-187
    1. Jahangiri A., Wagner J., Tran M. T., Miller L. M., Tom M. W., Kunwar S., et al. . (2013). Factors predicting postoperative hyponatremia and efficacy of hyponatremia management strategies after more than 1000 pituitary operations. J. Neurosurg. 119, 1478–1483. 10.3171/2013.7.JNS13273
    1. Kalita J., Singh R. K., Misra U. K. (2017). Cerebral salt wasting is the most common cause of hyponatremia in stroke. J. Stroke Cerebrovasc. Dis. 26, 1026–1032. 10.1016/j.jstrokecerebrovasdis.2016.12.011
    1. Karandanis D., Shulman J. A. (1976). Recent survey of infectious meningitis in adults: review of laboratory findings in bacterial, tuberculous, and aseptic meningitis. South. Med. J. 69, 449–457. 10.1097/00007611-197604000-00021
    1. Kinik S. T., Kandemir N., Baykan A., Akalan N., Yordam N. (2001). Fludrocortisone treatment in a child with severe cerebral salt wasting. Pediatr. Neurosurg. 35, 216–219. 10.1159/000050424
    1. Kiran Z., Sheikh A., Momin S. N., Majeed I., Awan S., Rashid O., et al. . (2017). Sodium and water imbalance after sellar, suprasellar, and parasellar surgery. Endocr. Pract. 23, 309–317. 10.4158/EP161616.OR
    1. Kumar M., Kalita J., Misra U. K. (2019). Renal salt wasting in Guillain-Barre syndrome. Postgrad. Med. J. 95, 628–629. 10.1136/postgradmedj-2019-136870
    1. Lee J. J., Lee S. T., Jung K. H., Chu K., Lee S. K. (2013). Anti-LGI1 limbic encephalitis presented with atypical manifestations. Exp. Neurobiol. 22, 337–340. 10.5607/en.2013.22.4.337
    1. Lee P., Jones G. R., Center J. R. (2008). Successful treatment of adult cerebral salt wasting with fludrocortisone. Arch. Intern. Med. 168, 325–326. 10.1001/archinternmed.2007.126
    1. Lenhard T., Grimm C., Ringleb P. A. (2011). Renal salt wasting as part of dysautonomia in Guillain-Barre syndrome. J. Neurol. Neurosurg. Psychiatry 82, 1051–1053. 10.1136/jnnp.2009.192369
    1. Leonard J., Garrett R. E., Salottolo K., Slone D. S., Mains C. W., Carrick M. M., et al. . (2015). Cerebral salt wasting after traumatic brain injury: a review of the literature. Scand. J. Trauma Resusc. Emerg. Med. 23:98. 10.1186/s13049-015-0180-5
    1. Lohani S., Devkota U. P. (2011). Hyponatremia in patients with traumatic brain injury: etiology, incidence, and severity correlation. World Neurosurg. 76, 355–360. 10.1016/j.wneu.2011.03.042
    1. Maesaka J. K., Imbriano L., Mattana J., Gallagher D., Bade N., Sharif S. (2014). Differentiating SIADH from cerebral/renal salt wasting: failure of the volume approach and need for a new approach to hyponatremia. J. Clin. Med. 3, 1373–1385. 10.3390/jcm3041373
    1. Maesaka J. K., Imbriano L. J., Ali N. M., Ilamathi E. (2009). Is it cerebral or renal salt wasting? Kidney Int. 76, 934–938. 10.1038/ki.2009.263
    1. Maesaka J. K., Imbriano L. J., Miyawaki N. (2018). High prevalence of renal salt wasting without cerebral disease as cause of hyponatremia in general medical wards. Am. J. Med. Sci. 356, 15–22. 10.1016/j.amjms.2018.03.020
    1. McQuillan R. F., Bargman J. M. (2011). Hyponatraemia caused by LGI1-associated limbic encephalitis. NDT Plus 4, 424–426. 10.1093/ndtplus/sfr105
    1. Misra U. K., Kalita J., Bhoi S. K., Singh R. K. (2016). A study of hyponatremia in tuberculous meningitis. J. Neurol. Sci. 367, 152–157. 10.1016/j.jns.2016.06.004
    1. Misra U. K., Kalita J., Kumar M. (2018b). Safety and efficacy of fludrocortisone in the treatment of cerebral salt wasting in patients with tuberculous meningitis: a randomized clinical trial. JAMA Neurol. 75, 1383–1391. 10.1001/jamaneurol.2018.2178
    1. Misra U. K., Kalita J., Kumar M., Tripathi A. (2018a). A study of atrial and brain natriuretic peptides in tuberculous meningitis and acute encephalitis. Int. J. Tuberc. Lung Dis. 22, 452–457. 10.5588/ijtld.17.0479
    1. Misra U. K., Kalita J., Singh R. K., Bhoi S. K. (2019). A study of hyponatremia in acute encephalitis syndrome: a prospective study from a tertiary care center in India. J. Intensive Care Med. 34, 411–417. 10.1177/0885066617701422
    1. Monig H., Arlt A. (2017). Hyponatremia: differential diagnosis and treatment. Dtsch. Med. Wochenschr. 142, 1231–1247. 10.1055/s-0043-108953
    1. Monzon Vazquez T., Florit E., Marques Vidas M., Rodriguez Cubillo B., Delgado Conde P., Barrientos Guzman A. (2011). Syndrome of inappropriate antidiuretic hormone hypersecretion associated with Guillain-Barre syndrome. Nefrologia 31, 498–499. 10.3265/Nefrologia.pre2011
    1. Moritz M. L. (2019). Syndrome of inappropriate antidiuresis. Pediatr. Clin. North Am. 66, 209–226. 10.1016/j.pcl.2018.09.005
    1. Moro N., Katayama Y., Igarashi T., Mori T., Kawamata T., Kojima J. (2007). Hyponatremia in patients with traumatic brain injury: incidence, mechanism, and response to sodium supplementation or retention therapy with hydrocortisone. Surg. Neurol. 68, 387–393. 10.1016/j.surneu.2006.11.052
    1. Murthy S. B., Caplan J., Levy A. P., Pradilla G., Moradiya Y., Schneider E. B., et al. . (2016). Haptoglobin 2-2 genotype is associated with cerebral salt wasting syndrome in aneurysmal subarachnoid hemorrhage. Neurosurgery 78, 71–76. 10.1227/NEU.0000000000001000
    1. Nelson P. B., Seif S. M., Maroon J. C., Robinson A. G. (1981). Hyponatremia in intracranial disease: perhaps not the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J. Neurosurg. 55, 938–941. 10.3171/jns.1981.55.6.0938
    1. Palmer B. F. (2000). Hyponatraemia in a neurosurgical patient: syndrome of inappropriate antidiuretic hormone secretion versus cerebral salt wasting. Nephrol. Dial. Transplant. 15, 262–268. 10.1093/ndt/15.2.262
    1. Peri A., Giuliani C. (2014). Management of euvolemic hyponatremia attributed to SIADH in the hospital setting. Minerva Endocrinol. 39, 33–41.
    1. Peters J. P., Welt L. G., Sims E. A., Orloff J., Needham J. (1950). A salt-wasting syndrome associated with cerebral disease. Trans. Assoc. Am. Phys. 63, 57–64.
    1. Rahman M., Friedman W. A. (2009). Hyponatremia in neurosurgical patients: clinical guidelines development. Neurosurgery 65, 925–935; discussion 935–926. 10.1227/01.NEU.0000358954.62182.B3
    1. Raymond I., Groenning B. A., Hildebrandt P. R., Nilsson J. C., Baumann M., Trawinski J., et al. . (2003). The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 89, 745–751. 10.1136/heart.89.7.745
    1. Robertson G. L. (2006). Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am. J. Med. 119, S36–42. 10.1016/j.amjmed.2006.05.006
    1. Rother R. P., Bell L., Hillmen P., Gladwin M. T. (2005). The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 293, 1653–1662. 10.1001/jama.293.13.1653
    1. Rumalla K., Reddy A. Y., Letchuman V., Mittal M. K. (2017). Hyponatremia in Guillain-Barre syndrome. J. Clin. Neuromuscul. Dis. 18, 207–217. 10.1097/CND.0000000000000157
    1. Saifudheen K., Jose J., Gafoor V. A., Musthafa M. (2011). Guillain-Barre syndrome and SIADH. Neurology 76, 701–704. 10.1212/WNL.0b013e31820d8b40
    1. Sakarcan A., Bocchini J., Jr. (1998). The role of fludrocortisone in a child with cerebral salt wasting. Pediatr. Nephrol. 12, 769–771. 10.1007/s004670050543
    1. Saleem S., Yousuf I., Gul A., Gupta S., Verma S. (2014). Hyponatremia in stroke. Ann. Indian Acad. Neurol. 17, 55–57. 10.4103/0972-2327.128554
    1. Schrier R. W., Gross P., Gheorghiade M., Berl T., Verbalis J. G., Czerwiec F. S., et al. . (2006). Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N. Engl. J. Med. 355, 2099–2112. 10.1056/NEJMoa065181
    1. Schwartz W. B., Bennett W., Curelop S., Bartter F. C. (1957). A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am. J. Med. 23, 529–542. 10.1016/0002-9343(57)90224-3
    1. Shen B., Li L., Li T. (2017). Concurrence of inappropriate antidiuretic hormone secretion and cerebral salt wasting syndromes after traumatic brain injury. Front. Neurosci. 11:499. 10.3389/fnins.2017.00499
    1. Sherlock M., O'Sullivan E., Agha A., Behan L. A., Rawluk D., Brennan P., et al. . (2006). The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clin. Endocrinol. 64, 250–254. 10.1111/j.1365-2265.2006.02432.x
    1. Shippy C. R., Appel P. L., Shoemaker W. C. (1984). Reliability of clinical monitoring to assess blood volume in critically ill patients. Crit. Care Med. 12, 107–112. 10.1097/00003246-198402000-00005
    1. Singh S., Bohn D., Carlotti A. P., Cusimano M., Rutka J. T., Halperin M. L. (2002). Cerebral salt wasting: truths, fallacies, theories, and challenges. Crit. Care Med. 30, 2575–2579. 10.1097/00003246-200211000-00028
    1. Sonnenblick M., Rosin A. (1988). Increased uric acid clearance in the syndrome of inappropriate secretion of antidiuretic hormone. Isr. J. Med. Sci. 24, 20–23.
    1. Spasovski G., Vanholder R., Allolio B., Annane D., Ball S., Bichet D., et al. . (2014). Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol. Dial. Transplant. 29 (Suppl. 2), i1–i39. 10.1093/ndt/gfu040
    1. Steinberger B. A., Ford S. M., Coleman T. A. (2003). Intravenous immunoglobulin therapy results in post-infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia. Am. J. Hematol. 73, 97–100. 10.1002/ajh.10325
    1. Sturdik I., Adamcova M., Kollerova J., Koller T., Zelinkova Z., Payer J. (2014). Hyponatraemia is an independent predictor of in-hospital mortality. Eur. J. Intern. Med. 25, 379–382. 10.1016/j.ejim.2014.02.002
    1. Taniguchi K., Tamura Y., Kumagai T., Shibata S., Uchida S. (2016). Stimulation of V1a receptor increases renal uric acid clearance via urate transporters: insight into pathogenesis of hypouricemia in SIADH. Clin. Exp. Nephrol. 20, 845–852. 10.1007/s10157-016-1248-x
    1. Taylor P., Dehbozorgi S., Tabasum A., Scholz A., Bhatt H., Stewart P., et al. (2017). Cerebral salt wasting following traumatic brain injury. Endocrinol. Diabetes Metab. Case Rep. 4:16–0142. 10.1530/EDM-16-0142
    1. Thajudeen B., Salahudeen A. K. (2016). Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives. Cancer Manag. Res. 8, 105–114. 10.2147/CMAR.S90169
    1. Tisdall M., Crocker M., Watkiss J., Smith M. (2006). Disturbances of sodium in critically ill adult neurologic patients: a clinical review. J. Neurosurg. Anesthesiol. 18, 57–63. 10.1097/01.ana.0000191280.05170.0f
    1. Tobin G., Chacko A. G., Simon R. (2018). Evaluation of NT-ProBNP as a marker of the volume status of neurosurgical patients developing hyponatremia and natriuresis: a pilot study. Neurol. India 66, 1383–1388. 10.4103/0028-3886.241401
    1. Towfighi A., Ovbiagele B., Saver J. L. (2010). Therapeutic milestone: stroke declines from the second to the third leading organ- and disease-specific cause of death in the United States. Stroke 41, 499–503. 10.1161/STROKEAHA.109.571828
    1. Upadhyay U. M., Gormley W. B. (2012). Etiology and management of hyponatremia in neurosurgical patients. J. Intensive Care Med. 27, 139–144. 10.1177/0885066610395489
    1. von Vigier R. O., Colombo S. M., Stoffel P. B., Meregalli P., Truttmann A. C., Bianchetti M. G. (2001). Circulating sodium in acute meningitis. Am. J. Nephrol. 21, 87–90. 10.1159/000046229
    1. Williams C. N., Riva-Cambrin J., Bratton S. L. (2016). Etiology of postoperative hyponatremia following pediatric intracranial tumor surgery. J. Neurosurg. Pediatr. 17, 303–309. 10.3171/2015.7.PEDS15277
    1. Yee A. H., Burns J. D., Wijdicks E. F. (2010). Cerebral salt wasting: pathophysiology, diagnosis, and treatment. Neurosurg. Clin. N. Am. 21, 339–352. 10.1016/j.nec.2009.10.011
    1. Yoon H. K., Lee H. C., Kim Y. H., Lim Y. J., Park H. P. (2019). Predictive factors for delayed hyponatremia after endoscopic transsphenoidal surgery in patients with nonfunctioning pituitary tumors: a retrospective observational study. World Neurosurg. 122, e1457–e1464. 10.1016/j.wneu.2019.09.146
    1. Yumoto T., Sato K., Ugawa T., Ichiba S., Ujike Y. (2015). Prevalence, risk factors, and short-term consequences of traumatic brain injury-associated hyponatremia. Acta Med. Okayama 69, 213–218. 10.18926/AMO/53557
    1. Zerbe R., Stropes L., Robertson G. (1980). Vasopressin function in the syndrome of inappropriate antidiuresis. Annu. Rev. Med. 31, 315–327. 10.1146/annurev.me.31.020180.001531

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する